Haisco Pharmaceutical Group Co., Ltd.
002653
Classement en actions
#2011
Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates... Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates within China, focusing on the research, production, and distribution of a diverse range of pharmaceutical products. Their offerings span various dosage forms, including small and large volume injections, freeze-dried and conventional powder injections, and active pharmaceutical ingredients (APIs). These medications target numerous therapeutic areas such as anti-infectives, digestive system disorders, blood system conditions, nervous system ailments, parenteral nutrition, antibiotics, emergency care, anesthesiology, and oncology. Furthermore, the company provides drugs in tablet, capsule, granule, and ointment forms for cardiovascular health, infectious diseases, digestive issues, central nervous system (CNS) conditions, diabetes, and hepatic diseases. Established in 2000 and based in Shannan, China, the company adopted its current name, Haisco Pharmaceutical Group Co., Ltd., in March 2016, having previously been known as Xizang Haisco Pharmaceutical Group Co., Ltd.
Prix de l'action
$9.03
Capitalisation boursière
$10.30B
Changement (1 jour)
4.55%
Changement (1 an)
24.15%
Pays
CN
Échange Haisco Pharmaceutical Group Co., Ltd. (002653)
Catégorie
Healthcare
Ratio P/B pour Haisco Pharmaceutical Group Co., Ltd. (002653)
Ratio P/B au October 2026 TTM : 12.97
Selon les derniers rapports financiers et le cours de l'action de Haisco Pharmaceutical Group Co., Ltd., le ratio cours/valeur comptable actuel (TTM) est 12.97. À la fin de 2023, le ratio P/B était de 6.30.
Historique du ratio P/B pour Haisco Pharmaceutical Group Co., Ltd. de 2008 à 2026
Ratio P/B à la fin de chaque année
| Année | Ratio P/B | Changez |
|---|---|---|
| 2026 (TTM) | 12.97 | 46.74% |
| 2024 | 8.84 | 40.24% |
| 2023 | 6.30 | -20.06% |
| 2022 | 7.88 | 2.00% |
| 2021 | 7.73 | 19.70% |
| 2020 | 6.46 | -29.69% |
| 2019 | 9.18 | 53.03% |
| 2018 | 6.00 | 4.90% |
| 2017 | 5.72 | -22.51% |
| 2016 | 7.38 | -31.60% |
| 2015 | 10.79 | 23.70% |
| 2014 | 8.72 | -21.38% |
| 2013 | 11.10 | 72.12% |
| 2012 | 6.45 | -27.45% |
| 2011 | 8.89 | -39.72% |
| 2010 | 14.74 | -68.96% |
| 2009 | 47.50 | 59.68% |
| 2008 | 29.74 | 0.00% |
Ratio P/B pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/B | Différence de Ratio P/B | Pays |
|---|---|---|---|
| 6.251 | -51.81% |
US
|
|
| 13.2547 | 2.18% |
US
|
|
| 4.208 | -67.56% |
AU
|
|
| 6.1824 | -52.34% |
NL
|
|
| - | - |
CH
|
